Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMAT vs MRNA✓SelectedUSD · MRNAAMAT vs MRNA performance historyLatest closeAs of+0.88%11/18
Stock and ETF performance explorer

AMAT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+131.3%
MRNA return
-20.0%
Excess return
+151.4%
Maximum drawdown
-55.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.9%-4.8%+5.7%+1.2%
7D-10.8%-20.9%+10.0%-9.3%
30D-14.7%-13.3%-1.5%-13.9%
3M-31.4%+212.6%-244.0%-40.9%
6M-14.6%+309.0%-323.7%-31.4%
YTD+37.6%+567.3%-529.7%-1.3%
1Y+57.4%+689.7%-632.3%+8.6%
3Y+142.7%+157.4%-14.7%+93.7%
5Y+131.3%-21.7%+153.0%+106.3%
All+131.3%-20.0%+151.4%+106.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling